Skip to main content
. 2019 Apr 1;5(4):312–316. doi: 10.1016/j.jdcr.2019.02.002

Fig 1.

Fig 1

Erythematous urticarial plaques most prominent on the left (A) and right (B) posterior thighs. Follow-up examination on day 9 after daily subcutaneous anakinra, 100 mg, shows complete resolution of skin lesions. Focal scar and dyspigmentation on the left (C) and right (D) thighs represent biopsy sites.